Fidelity Investments’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$334K Sell
19,292
-1,483,917
-99% -$25.7M ﹤0.01% 3119
2025
Q1
$32.9M Sell
1,503,209
-624,456
-29% -$13.7M ﹤0.01% 1521
2024
Q4
$67.9M Sell
2,127,665
-772,589
-27% -$24.7M ﹤0.01% 1273
2024
Q3
$83.6M Sell
2,900,254
-399,536
-12% -$11.5M 0.01% 1176
2024
Q2
$127M Buy
3,299,790
+1,121,048
+51% +$43M 0.01% 962
2024
Q1
$128M Buy
2,178,742
+86,278
+4% +$5.07M 0.01% 958
2023
Q4
$125M Sell
2,092,464
-167,302
-7% -$10M 0.01% 929
2023
Q3
$86M Sell
2,259,766
-1,965,829
-47% -$74.8M 0.01% 1043
2023
Q2
$385M Buy
4,225,595
+2,100,158
+99% +$191M 0.03% 492
2023
Q1
$140M Buy
2,125,437
+665,274
+46% +$43.9M 0.01% 864
2022
Q4
$75.5M Sell
1,460,163
-1
-0% -$52 0.01% 1079
2022
Q3
$99.7M Buy
1,460,164
+71,737
+5% +$4.9M 0.01% 959
2022
Q2
$62.8M Sell
1,388,427
-9,165
-0.7% -$414K 0.01% 1163
2022
Q1
$71M Sell
1,397,592
-217,267
-13% -$11M 0.01% 1244
2021
Q4
$76.4M Hold
1,614,859
0.01% 1235
2021
Q3
$53.2M Buy
1,614,859
+143,694
+10% +$4.74M ﹤0.01% 1381
2021
Q2
$93M Sell
1,471,165
-150,087
-9% -$9.49M 0.01% 1149
2021
Q1
$69.6M Buy
1,621,252
+481,526
+42% +$20.7M 0.01% 1236
2020
Q4
$65.2M Buy
1,139,726
+871,592
+325% +$49.9M 0.01% 1218
2020
Q3
$8.09M Sell
268,134
-230,088
-46% -$6.94M ﹤0.01% 1894
2020
Q2
$16.3M Sell
498,222
-20,312
-4% -$663K ﹤0.01% 1629
2020
Q1
$13.9M Sell
518,534
-20,900
-4% -$560K ﹤0.01% 1565
2019
Q4
$16.5M Buy
539,434
+166,300
+45% +$5.09M ﹤0.01% 1668
2019
Q3
$8.99M Buy
373,134
+10,000
+3% +$241K ﹤0.01% 1873
2019
Q2
$9.2M Sell
363,134
-294
-0.1% -$7.45K ﹤0.01% 1912
2019
Q1
$7.09M Sell
363,428
-106,400
-23% -$2.07M ﹤0.01% 1977
2018
Q4
$6.2M Sell
469,828
-97,500
-17% -$1.29M ﹤0.01% 1962
2018
Q3
$10.1M Sell
567,328
-775,812
-58% -$13.8M ﹤0.01% 1931
2018
Q2
$29.5M Buy
1,343,140
+345,376
+35% +$7.6M ﹤0.01% 1529
2018
Q1
$22.1M Buy
997,764
+693,847
+228% +$15.3M ﹤0.01% 1681
2017
Q4
$6.6M Buy
+303,917
New +$6.6M ﹤0.01% 2086